Sorrento Therapeutics Inc (SRNE): Paul Snowman points out that the strange...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: None

Wednesday, 01/25/2023 11:23:51 AM

Wednesday, January 25, 2023 11:23:51 AM

Paul Snowman points out that the strange Seeking Alpha article ignores SEMDEXA news!
The latest Seeking Alpha Alpha article mentions that Scilex "has a pipeline" but goes on to ignore the impact of advances in that pipeline!

It ignores the advance of SEMDEXA.

It ignores the advance of GLOPERBA.

It ignores the advance of SP-103.

It ignores the advance of SP-104.

There is news coming on all four programs this year. Scilex says the Global opportunity of these programs exceeds $40 Billion! The advance of these programs and world-wide partnering opportunities are what will drive the share price of Scilex. SEMDEXA has completed phase 3 and has Fast Track. SP-103 is Phase 3 ready and has Fast Track. And GLOPERBA has Marketing approval and will hit the market any day now! IT IS ADVANCES IN THE PIPELINE THAT WILL DRIVE THE SHARE PRICE!

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM